 |
 |
 |
|
Assessment of Regional Impact on the Pharmacokinetics of VIR-2218
(BRII-835) in Participants with Chronic Hepatitis B Infection
|
|
|
AASLD 2023 nov 10-14
https://www.aasld.org/the-liver-meeting
Yali Zhu1, Sneha V. Gupta2, Chunming Li1, Chong Zhu1, Xiaofei Chen1, Weihong Liu1 and Ji Ma1
1 Brii Biosciences Limited 2 Vir Biotechnology, Inc.







|
|
|
 |
 |
|
|